 |
市場調查報告書
商品編碼
1741359
大腸桿菌菌株市場：按菌株類型、按應用、按致病性、按最終用戶、按地區Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography |
||||||
大腸桿菌菌株市場規模預計在 2025 年達到 22.6 億美元，預計到 2032 年將達到 36.1 億美元，2025 年至 2032 年的複合年成長率為 6.9%。
| 分析範圍 | 分析詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 市場規模（2025年） | 22.6億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期內的複合年成長率（2025-2032） | 6.90% | 預計金額（2032年） | 36.1億美元 |
大腸桿菌，俗稱E. coli，是一種由於其多樣性和在研究中的廣泛應用而引起重大科學興趣的細菌菌株。該細菌屬於腸桿菌科，通常存在於人類和動物的消化道中。雖然大腸桿菌經常與食物中毒和感染疾病有關，但值得注意的是，並非所有菌株都是有害的。事實上，許多菌株是有益的，在消化器官系統中發揮重要作用，幫助分解食物和吸收營養。然而，一些大腸桿菌菌株是致病的，可引起各種疾病，從輕微的胃腸道疾病到嚴重的疾病，如尿道感染、肺炎，甚至危及生命的溶血性尿毒症綜合症。大腸桿菌能夠引起如此廣泛的疾病，使其成為一個重大的公共衛生問題。大腸桿菌的多樣性及其在健康和疾病中的作用使其成為科學研究極為重要的模型生物。大腸桿菌在遺傳學、生物化學和生物技術領域得到了廣泛的研究，大大促進了我們對這些領域的理解。研究人員利用大腸桿菌研究細菌遺傳學、代謝途徑，並開發新的生物技術應用。這項廣泛的研究不僅加深了我們對細菌本身的認知，也為更廣泛的生物過程提供了寶貴的見解。
市場動態：
生物技術研究、重組蛋白生產和藥物開發預計將在預測期內推動全球大腸桿菌菌株市場的成長。此外，工業生產也有望在預測期內推動全球大腸桿菌菌株市場的成長。生物製藥生產、合成生物學、個人化醫療和生物修復預計將在預測期內為全球大腸桿菌市場提供成長機會。
然而，預計安全和生物安全問題、監管障礙、與其他微生物的競爭以及污染和交叉污染的風險將在預測期內阻礙大腸桿菌菌株市場的成長。
本報告的主要特點
- 本報告對全球大腸桿菌菌株市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
- 它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 全球大腸桿菌菌株市場的主要企業簡介根據以下參數列出，例如公司概況、產品系列、主要亮點、財務績效和策略。
- 透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
- 「大腸桿菌菌株市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過用於分析全球大腸桿菌菌株市場的各種策略矩陣來促進他們的決策。
目錄
第1章 分析目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map (COM)
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 預計生物技術研究將在預測期內推動市場成長
- 限制因素
- 預計對安全和生物安全的擔憂將在預測期內阻礙市場成長。
- 機會
- 個人化醫療，為精準醫療應用提供客製化的大腸桿菌菌株，預計將提供市場機會。
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- 波特五力分析
- 企業合併（M&A）和聯盟分析
4. 大腸桿菌菌株市場：COVID-19感染疾病的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
5. 大腸桿菌菌株市場（依菌株類型分類）（2020-2032）
- 共生菌株
- 引起腹瀉的菌株
- 腸外致病菌株
- 泌尿道致病菌株
- 新生兒腦膜炎雙球菌菌株
- 其他
第6章 大腸桿菌菌株市場：依應用（2020-2032 年）
- 診斷
- 研究
- 治療
- 重組蛋白生產
- 品管生物體
- 其他
第7章 大腸桿菌菌株市場：致病性（2020-2032）
- 致病性大腸桿菌
- 非致病性大腸桿菌
8. 大腸桿菌菌株市場（依最終用戶分類）（2020-2032 年）
- 研究所
- 診斷實驗室
- 製藥和生物技術公司
- CRO（委外研發機構）
- 其他
9. 大腸桿菌菌株市場（按地區分類） (2020-2032)
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Novozymes A/S
- QIAGEN NV
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- Sanofi
- Xiamen Innovax Biotech Co., Ltd
第 11 章 章節
- 參考
- 調查方法
- 關於出版商
Escherichia Coli Strain Market is estimated to be valued at USD 2.26 Bn in 2025 and is expected to reach USD 3.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.26 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.90% | 2032 Value Projection: | USD 3.61 Bn |
Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.
Market Dynamics:
Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.
However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market
Detailed Segmentation:
- Escherichia Coli Strain Market, By Strain Type:
- Commensal strains
- Diarrheal strains
- Extraintestinal pathogenic strains
- Uropathogenic strains
- Neonatal meningitis strains
- Others
- Escherichia Coli Strain Market, By Application:
- Diagnostics
- Research
- Therapeutics
- Production of recombinant proteins
- Quality control organisms
- Others
- Escherichia Coli Strain Market, By Pathogenicity:
- Pathogenic E. coli
- Non-pathogenic E. coli
- Escherichia Coli Strain Market, By End User:
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
- Escherichia Coli Strain Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Novozymes A/S
- QIAGEN N.V.
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- Sanofi
- Xiamen Innovax Biotech Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Strain Type
- Market Snippet, By Application
- Market Snippet, By Pathogenicity
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Biotechnology research is expected to drive the market growth over forecast period
- Restraints
- Safety and biosecurity concerns is expected to hinder the market growth over forecast period
- Opportunities
- Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Escherichia Coli Strain Market, By Strain Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Commensal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diarrheal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Extraintestinal pathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Uropathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Neonatal meningitis strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Escherichia Coli Strain Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Production of recombinant proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Quality control organisms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%) Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Non-pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Escherichia Coli Strain Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Escherichia Coli Strain Market, By Geography, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profile
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novozymes A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Xiamen Innovax Biotech Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us
